Nimbus Therapeutics logo

Nimbus Therapeutics

We develop breakthrough medicines for patients through precision small molecule design.

99 employees · est. 2009 · Boston, United States

VS
Treeline logo

Treeline

Making medicines at the highest level

172 employees · est. 2021 · Watertown, United States

Nimbus Therapeutics is the older company (2009 vs 2021).

Side-by-Side Comparison

Nimbus Therapeutics Treeline
Founded
2009 older 2021
Headquarters
Boston, United States Watertown, United States
Employees
99 172
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Life Sciences
Funding Stage
Private Equity Series A
Total Funding
$637.00M $473.27M
Funding Rounds
9 2
Services
Target Selection, Drug Discovery, Translational Medicine, Clinical Development, Development of Small Molecule Medicines Medicine Development, Research and Development, Protein Target Analysis, Drug Candidate Design
Target Customers
Patients with Oncology Conditions, Patients with Immunological Disorders, Patients with Metabolic Indications, Biotechnology and Pharmaceutical Corporations, Healthcare Professionals Patients with Cancer, Patients with Autoimmune Diseases, Patients with Neurological Diseases
Taxonomy
Precision Medicine, Small Molecule Design, Structure-based Drug Discovery, Computational Technologies, Machine Learning In Drug Development, Clinical-stage Therapeutics, Oncology, Immunology, Metabolic Diseases, Cancer Treatment, Autoimmune Conditions, HPK1 Inhibitor, WRN Program, Computational Chemistry Biopharma, Clinical-stage, Precision Medicine, Oncology, Cancer Treatment, Serious Diseases, Drug Development, R&D, Computational Tools, Biology, Chemistry, Protein Science, Clinical Development, Transformative Medicine, Disease Targets
Website
nimbustx.com treeline.bio
Nimbus Therapeutics logo

About Nimbus Therapeutics

Nimbus Therapeutics, founded in 2009, is a pioneering biotechnology company headquartered in the United States. The company is dedicated to developing breakthrough medicines through precision small molecule design, leveraging sophisticated computational technologies and machine learning-based predic...

Treeline logo

About Treeline

Treeline, a privately held, clinical-stage biopharmaceutical company founded in 2021, carries the ambitious slogan: "Making medicines at the highest level." Operating across the United States and Europe, the company focuses on leveraging cutting-edge computational tools to match disease targets with...

We will tell you when either one moves

BounceWatch watches Nimbus Therapeutics and Treeline for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Nimbus Therapeutics and Treeline — by email.

Frequently Asked Questions

Nimbus Therapeutics — We develop breakthrough medicines for patients through precision small molecule design.. Treeline — Making medicines at the highest level. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Nimbus Therapeutics has raised $637.00M while Treeline has raised $473.27M.
Nimbus Therapeutics and Treeline operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Nimbus Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Nimbus Therapeutics on 15 Jun 2026, and Treeline on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes